Catecholamine vasopressor / inotrope (dose-dependent)
Pregnancy: Use only in life-threatening emergency.
Dopamine
Brand names: Dopamine Injection
Adult dose
Dose: Low: 2–4 mcg/kg/min (renal vasodilation); Medium: 5–10 mcg/kg/min (cardiac); High: 10–20+ mcg/kg/min (vasoconstriction)
Route: IV infusion (central line preferred)
Frequency: Continuous infusion, titrated
Max: 20 mcg/kg/min (standard); higher possible in extremis
'Low-dose dopamine' for renal protection is NOT evidence-based (ANZICS trial). Use for shock when both inotropy and vasopressor needed. Increasingly replaced by noradrenaline ± dobutamine. Central line preferred (peripheral extravasation causes necrosis).
Paediatric dose
Dose: 5 mcg/min/kg
Route: IV central
Frequency: Continuous infusion
Max: 20 micrograms/kg/min
Concentration: 1600 mcg/min/ml
2–20 mcg/kg/min. Weight-based calculation essential. Neonatal: 2–5 mcg/kg/min for renal and cardiac support. Weight-based drug tables (Broselow) used in paediatric emergencies.
Dose adjustments
Renal
Low-dose dopamine for renal protection is NOT recommended.
Hepatic
No specific adjustment.
Paediatric weight-based calculator
2–20 mcg/kg/min. Weight-based calculation essential. Neonatal: 2–5 mcg/kg/min for renal and cardiac support. Weight-based drug tables (Broselow) used in paediatric emergencies.
Clinical pearls
- No role for 'renal-dose dopamine' — abandoned (ANZICS trial 2000)
- SOAP-II: noradrenaline preferred over dopamine (fewer arrhythmias in septic shock)
- High-dose dopamine increasingly replaced by noradrenaline + dobutamine combination
- Peripheral extravasation: treat immediately with phentolamine 5 mg in 10 mL saline injected into affected area
- MAOI interaction critical — check medication history
Contraindications
- Phaeochromocytoma
- Uncorrected tachyarrhythmias
- Ventricular fibrillation
Side effects
- Tachycardia and arrhythmias (more than noradrenaline)
- Hypertension or hypotension
- Necrosis and gangrene (peripheral extravasation)
- Nausea and vomiting
- Ischaemia (high doses)
Interactions
- MAOIs — greatly increase pressor response (reduce dose to 1/10th)
- Phenytoin — hypotension and bradycardia with IV combination
- Halothane — cardiac arrhythmias
Monitoring
- Cardiac rhythm (ECG)
- BP
- Urine output
- Peripheral perfusion
Reference: BNFc; BNF; SOAP-II trial; ANZICS trial; Surviving Sepsis Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
- Acute Chest Pain · NICE CG95; ESC 2023 ACS Guidelines